Why the study?
Does intravenous thrombolytic therapy improve mortality in selected patients with acute myocardial infarction and unstable angina?
Population
Patients with acute myocardial infarction and unstable angina
Design
Systematic_review
Authors
Loading...
Supports expanding thrombolysis eligibility to select high-risk AMI subgroups; extends evidence base but confirms no benefit in unstable angina.
Does intravenous thrombolytic therapy improve mortality in selected patients with acute myocardial infarction and unstable angina?
This review suggests that the eligibility criteria for thrombolytic therapy in acute myocardial infarction could be expanded to include certain high-risk subgroups, but it is not supported for unstable angina.
David W. Muller (1990) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: